Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Kidney Diseases (Basel, Switzerland)|June 28, 2021
Tackling Dialysis Burden around the World: A Global ChallengePhilip Kam-Tao Li, Gordon Chun-Kau Chan, Jianghua Chen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 25, 2006
Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled studyPhilip Kam-Tao Li, Chi Bon Leung, Kai Ming Chow, et al.
Nephrology (Carlton, Vic.)|November 21, 2017
Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort studyPhilip Kam-Tao Li, Jack Kit-Chung Ng, Yuk Lun Cheng, et al.
Plos Medicine|July 30, 2020
Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes BiobankGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
Diabetes|January 19, 2022
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 DiabetesGuozhi Jiang, Andrea O Luk, Claudia H T Tam, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2022
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes BiobankQiao Jin, Andrea O Luk, Eric S H Lau, et al.
Cardiovascular Diabetology|December 31, 2022
High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes BiobankQiao Jin, Eric S H Lau, Andrea O Luk, et al.
Diabetologia|November 12, 2024
Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetesGechang Yu, Claudia H T Tam, Cadmon K P Lim, et al.
Genome Medicine|February 20, 2021
Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East AsiansClaudia H T Tam, Cadmon K P Lim, Andrea O Y Luk, et al.
Diabetologia|February 27, 2024
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes BiobankQiao Jin, Eric S H Lau, Andrea O Luk, et al.
Pageof 5